Skip to content
Research Article Open access CC BY 4.0

Early Pregnancy Maternal Hepatocyte Growth Factor and Risk of Gestational Diabetes

Michal Dishi, Karin Hevner, Chunfang Qiu, Neway G. Fida, Dejene F. Abetew, Michelle A. Williams, Daniel A. Enquobahrie

Journal of Advances in Medicine and Medical Research · pp. 1–9 · Published 11 Jun 2015

10.9734/BJMMR/2015/18632

Abstract

Aims: We investigated associations of serum hepatocyte growth factor (HGF) with risk of gestational diabetes mellitus (GDM). We also examined whether pre-pregnancy overweight/obesity status or leisure-time physical activity (LTPA) modify these associations. Methods: In a nested case-control study (173 GDM cases and 187 controls) among participants of a pregnancy cohort, early pregnancy (16 weeks of gestation, on average) serum HGF was measured using enzyme-linked immunoassay. GDM was diagnosed using American Diabetes Association guidelines. Logistic regression was used to calculate odd ratios (ORs) and 95% confidence intervals (CI). Effect modifications by pre-pregnancy overweight/obesity status or LTPA during pregnancy were examined using stratified analyses and interaction terms. Results: Overall, we did not find significant associations of serum HGF with GDM risk (p-value>0.05). However, compared with women who had low serum HGF concentrations (<2.29 ng/ml), women with high serum HGF concentrations (≥ 2.29 ng/ml) had 3.8-fold (95%CI: 1.30-10.98) and 4.5-fold (95%CI: 1.28-15.80) higher GDM risk among women who were overweight/obese, pre-pregnancy (body mass index≥25 kg/m2), or did not report LTPA, respectively. These associations were not present among women who were not overweight/obese (interaction p=0.05) or reported LTPA (interaction p=0.05). Conclusion: Overweight/obesity status and LTPA may modify associations of early pregnancy serum HGF with subsequent GDM risk.

Hepatocyte growth factor gestational diabetes mellitus obesity physical activity.

Cited by 20

Beta-cell compensation and gestational diabetes.

Usman TO, Chhetri G, Yeh H · J Biol Chem · 2023

Levels of metabolic markers in drug-naive prediabetic and type 2 diabetic patients.

Akour A, Kasabri V, Boulatova N · Acta Diabetol · 2017

Showing 19 of 20 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

37

Page views

0

PDF downloads

4

Outbound clicks

20

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.